Atlanta, Georgia

Assessment of Needs

Rapid advances in HIV disease management require the ongoing attention of practitioners involved in HIV medicine. This course will address the implications of new information on strategies for clinical management. Information will be presented through a mix of didactic lectures and clinically relevant cases developed by an expert faculty of HIV/AIDS clinicians and researchers.

Learning Objectives

After participating in the activity, learners will be better able to:

• Apply newly available data on HIV management that includes antiretroviral strategies for medical care of people with established HIV infection
• Identify situations in which antiretroviral regimens should consider particular clinical circumstances, such as comorbid conditions, coinfections, pregnancy, and issues in older patients
• Describe the most current data on investigational new drugs and approaches
• Describe the strategies and challenges in achieving HIV eradication and remission
• Increase primary prevention through use of preexposure prophylaxis (PrEP) by determining which patients might benefit from PrEP and initiate and monitor use of PrEP for uninfected patients at risk for HIV infection
• Incorporate selected aspects of primary care for individuals with HIV infection, especially in the aging population, which may include: screening for cancer, sexually transmitted infections and opportunistic infections screening, treatment, and prevention; renal disease; cardiovascular disease; bone disease; endocrine disorders; and neurocognitive disorders
• Describe current diagnostic and treatment strategies for syphilis, gonorrhea, and chlamydia in the era of emerging antimicrobial resistance
• Formulate treatment strategies for the management of hepatitis-related liver complications for the nonhepatologist
• Describe the array of infectious and other complications that may arise with immunobiologic agents used by individuals with HIV infection

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

The ACCME defines a commercial interest as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.”

Registration

Who Should Attend

This course is designed for physicians who are actively involved in the medical care of people with HIV infection and:

• Have a solid, working knowledge of HIV disease management
• Provide comprehensive or specialty care for patients with HIV infection
• Are currently active in HIV research

This activity is also relevant to nurse practitioners, registered nurses, physician assistants, registered pharmacists, and other health professionals.

Representatives and employees of commercial companies (eg, pharmaceutical, diagnostic, medical products, advertising, insurance, investment, and communications firms) must contact the IAS–USA regarding registration procedures.

Cancellation Policy

Cancellation requests must be made 8 or more days before the date of an activity. All refunds will be processed minus a $15.00 processing charge. Regrettably, any cancellation requests received within a week before the course will not be eligible for the partial refund.